Who
Kevin R. Sayer
Executive Chair
Company insider
Files Form 4 as: Executive Chair, DexCom; Director, Akesis Pharmaceuticals.
In numbers
- Trades disclosed
- 393
- Buys
- 0
- Sells
- 83
- Bought
- $0
- Sold
- $202.4M
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 30 Dec 2005
- Last trade
- 20 Aug 2026
- Last filed
- 24 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 20 Aug 2026filed 24 Aug 2026 | DXCM DexComMedical Devices | SEC FORM 4 Sold | $1.7M19,308 at $89.71 | filing |
| 20 Aug 2026filed 24 Aug 2026 | DXCM DexComMedical Devices | SEC FORM 4 Sold | $667K7,351 at $90.78 | filing |
| 20 Aug 2026filed 24 Aug 2026 | DXCM DexComMedical Devices | SEC FORM 4 Sold | $8,86797 at $91.41 | filing |
| 20 Aug 2026filed 24 Aug 2026 | DXCM DexComMedical Devices | SEC FORM 4 Sold | $1.7M19,308 at $89.71 | filing |
| 20 Aug 2026filed 24 Aug 2026 | DXCM DexComMedical Devices | SEC FORM 4 Sold | $667K7,351 at $90.78 | filing |
| 20 Aug 2026filed 24 Aug 2026 | DXCM DexComMedical Devices | SEC FORM 4 Sold | $8,86797 at $91.41 | filing |
| 20 Jul 2026filed 21 Jul 2026 | DXCM DexComMedical Devices | SEC FORM 4 Sold | $2.0M26,756 at $76.32 | filing |
| 20 Jul 2026filed 21 Jul 2026 | DXCM DexComMedical Devices | SEC FORM 4 Sold | $2.0M26,756 at $76.32 | filing |
| 6 Jul 2026filed 7 Jul 2026 | DXCM DexComMedical Devices | SEC FORM 4 Sold | $1.9M26,756 at $72.00 | filing |
| 6 Jul 2026filed 7 Jul 2026 | DXCM DexComMedical Devices | SEC FORM 4 Sold | $1.9M26,756 at $72.00 | filing |
| 21 May 2026filed 26 May 2026 | DXCM DexComMedical Devices | SEC FORM 4 Sold | $1.9M26,759 at $72.00 | filing |
| 21 May 2026filed 26 May 2026 | DXCM DexComMedical Devices | SEC FORM 4 Sold | $1.9M26,759 at $72.00 | filing |
| 8 Mar 2026filed 10 Mar 2026 | DXCM DexComMedical Devices | SEC FORM 4 Code A | —32,749 at $0.00 | filing |
| 8 Mar 2026filed 10 Mar 2026 | DXCM DexComMedical Devices | SEC FORM 4 Code F | $2.2M32,498 at $68.10 | filing |
| 8 Mar 2026filed 10 Mar 2026 | DXCM DexComMedical Devices | SEC FORM 4 Code A | —32,749 at $0.00 | filing |
| 8 Mar 2026filed 10 Mar 2026 | DXCM DexComMedical Devices | SEC FORM 4 Code F | $2.2M32,498 at $68.10 | filing |
| 29 Jan 2026filed 2 Feb 2026 | DXCM DexComMedical Devices | SEC FORM 4 Code A | —71,218 at $0.00 | filing |
| 29 Jan 2026filed 2 Feb 2026 | DXCM DexComMedical Devices | SEC FORM 4 Code F | $2.5M34,257 at $73.36 | filing |
| 29 Jan 2026filed 2 Feb 2026 | DXCM DexComMedical Devices | SEC FORM 4 Code A | —71,218 at $0.00 | filing |
| 29 Jan 2026filed 2 Feb 2026 | DXCM DexComMedical Devices | SEC FORM 4 Code F | $2.5M34,257 at $73.36 | filing |
News
Vontobel Holding Ltd. Sells 14,970 Shares of DexCom, Inc. $DXCMDXCM · dailypolitical.com · 20 Oct 2026
0 headlines in the last 90 days name Kevin R. Sayer; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.